• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳香化酶抑制剂4-羟基雄烯二酮以及细胞色素P-450抑制剂磷酸氨基导眠能和酮康唑可抑制猪颗粒细胞在体外生成4-雌烯-3,17-二酮(19-去甲雄烯二酮)。

Formation of 4-oestrene-3,17-dione (19-norandrostenedione) by porcine granulosa cells in vitro is inhibited by the aromatase inhibitor 4-hydroxyandrostenedione and the cytochrome P-450 inhibitors aminoglutethimide phosphate and ketoconazole.

作者信息

Khalil M W, Morley P, Glasier M A, Armstrong D T, Lang T

机构信息

MRC Group in Reproductive Biology, University of Western Ontario, London, Canada.

出版信息

J Endocrinol. 1989 Feb;120(2):251-60. doi: 10.1677/joe.0.1200251.

DOI:10.1677/joe.0.1200251
PMID:2926299
Abstract

The origin and biosynthesis of 4-oestrene-3,17-dione (19-norandrostenedione), a major steroid in porcine ovarian follicular fluid, was investigated by culturing granulosa cells from 4-6 mm follicles of prepubertal gilts with radiolabelled androstenedione and 19-hydroxyandrostenedione. Steroid metabolites were purified by solvent extraction and lipophilic column chromatography, and analysed by C18 reverse-phase high-performance liquid chromatography. 19-Hydroxyandrostenedione, 19-norandrostenedione and oestradiol-17 beta were obtained as major metabolites from androstenedione, while 19-norandrostenedione and oestradiol-17 beta were the major products from 19-hydroxyandrostenedione. Serum alone or serum plus FSH significantly enhanced formation of 19-norandrostenedione and oestradiol-17 beta from each substrate, compared with controls. Micromolar concentrations (1 mumol/l) of 4-hydroxyandrostenedione, an aromatase inhibitor, significantly reduced formation of 19-norandrostenedione and oestradiol-17 beta by granulosa cells cultured with serum and FSH. Formation of 19-norandrostenedione and oestradiol-17 beta from androstenedione and 19-hydroxyandrostenedione was also significantly inhibited by aminoglutethimide phosphate, a cytochrome P-450 inhibitor known to block the conversion of androstenedione to oestrogens. Ketoconazole, an inhibitor of the cytochrome P-450 dependent 17,20-lysase, blocked formation of 19-norandrostenedione and oestradiol-17 beta only at millimolar concentrations. These results suggest that 19-norsteroid and oestrogen formation from C19 aromatizable androgens may share a common or overlapping pathway, and imply that 19-norsteroid and oestrogen synthesis is mediated by cytochrome P-450 dependent enzymes.

摘要

通过用放射性标记的雄烯二酮和19-羟基雄烯二酮培养青春期前小母猪4-6毫米卵泡的颗粒细胞,研究了猪卵巢卵泡液中的主要类固醇4-雌烯-3,17-二酮(19-去甲雄烯二酮)的来源和生物合成。类固醇代谢物通过溶剂萃取和亲脂性柱色谱法纯化,并通过C18反相高效液相色谱法进行分析。从雄烯二酮中获得了19-羟基雄烯二酮、19-去甲雄烯二酮和雌二醇-17β作为主要代谢物,而从19-羟基雄烯二酮中获得的主要产物是19-去甲雄烯二酮和雌二醇-17β。与对照组相比,单独的血清或血清加促卵泡素(FSH)显著增强了每种底物生成19-去甲雄烯二酮和雌二醇-17β的能力。微摩尔浓度(1μmol/l)的4-羟基雄烯二酮(一种芳香化酶抑制剂)显著降低了用血清和FSH培养的颗粒细胞生成19-去甲雄烯二酮和雌二醇-17β的能力。磷酸氨基谷氨酰胺(一种已知可阻断雄烯二酮向雌激素转化的细胞色素P-450抑制剂)也显著抑制了雄烯二酮和19-羟基雄烯二酮生成19-去甲雄烯二酮和雌二醇-17β。酮康唑(一种细胞色素P-450依赖性17,20-裂解酶抑制剂)仅在毫摩尔浓度下阻断了19-去甲雄烯二酮和雌二醇-17β的生成。这些结果表明,由C19可芳香化雄激素生成19-去甲类固醇和雌激素可能共享一条共同或重叠的途径,并暗示19-去甲类固醇和雌激素的合成是由细胞色素P-450依赖性酶介导的。

相似文献

1
Formation of 4-oestrene-3,17-dione (19-norandrostenedione) by porcine granulosa cells in vitro is inhibited by the aromatase inhibitor 4-hydroxyandrostenedione and the cytochrome P-450 inhibitors aminoglutethimide phosphate and ketoconazole.芳香化酶抑制剂4-羟基雄烯二酮以及细胞色素P-450抑制剂磷酸氨基导眠能和酮康唑可抑制猪颗粒细胞在体外生成4-雌烯-3,17-二酮(19-去甲雄烯二酮)。
J Endocrinol. 1989 Feb;120(2):251-60. doi: 10.1677/joe.0.1200251.
2
Formation and metabolism of 5(10)-estrene-3 beta,17 beta-diol, a novel 19-norandrogen produced by porcine granulosa cells from C19 aromatizable androgens.5(10)-雌烯-3β,17β-二醇的形成与代谢,一种由猪颗粒细胞从可芳香化的C19雄激素产生的新型19-去甲雄激素。
Biochem Biophys Res Commun. 1988 Aug 30;155(1):144-50. doi: 10.1016/s0006-291x(88)81061-1.
3
Conversion of 5(10)-oestrene-3 beta,17 beta-diol to 19-nor-4-ene-3-ketosteroids by luteal cells in vitro: possible involvement of the 3 beta-hydroxysteroid dehydrogenase/isomerase.体外黄体细胞将5(10)-雌甾烯-3β,17β-二醇转化为19-去甲-4-烯-3-酮甾体:3β-羟基类固醇脱氢酶/异构酶可能参与其中。
J Endocrinol. 1991 May;129(2):233-43. doi: 10.1677/joe.0.1290233.
4
Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.芳香化酶抑制剂对大鼠肝脏中雌激素2-羟化酶的影响。
J Steroid Biochem Mol Biol. 1994 Feb;48(2-3):215-9. doi: 10.1016/0960-0760(94)90147-3.
5
Androgen metabolism by porcine granulosa cells during the process of luteinization in vitro: identification of 19-oic-androstenedione as a major metabolite and possible precursor for the formation of C18 neutral steroids.
Endocrinology. 1991 Dec;129(6):2941-50. doi: 10.1210/endo-129-6-2941.
6
Identification and measurement of 4-oestren-3,17-dione (19-norandrostenedione) in porcine ovarian follicular fluid using high performance liquid chromatography and capillary gas chromatography-mass spectrometry.使用高效液相色谱法和毛细管气相色谱 - 质谱法鉴定和测定猪卵巢卵泡液中的4 - 雌烯 - 3,17 - 二酮(19 - 去甲雄烯二酮)
J Endocrinol. 1985 Dec;107(3):375-81. doi: 10.1677/joe.0.1070375.
7
The synthesis of 19-norandrostenedione from dehydroepiandrosterone in equine placenta is inhibited by aromatase inhibitors 4-hydroxyandrostenedione and fadrozole.芳香化酶抑制剂4-羟基雄烯二酮和法倔唑可抑制马胎盘组织中脱氢表雄酮合成19-去甲雄烯二酮的过程。
Comp Biochem Physiol B Biochem Mol Biol. 1995 Dec;112(4):613-8. doi: 10.1016/0305-0491(95)00117-4.
8
In vitro 19-norandrogen synthesis by equine placenta requires the participation of aromatase.
J Endocrinol. 1995 Mar;144(3):517-25. doi: 10.1677/joe.0.1440517.
9
Alterations in granulosa cell aromatase activity accompanying preovulatory follicular development in the rat ovary with evidence that 5alpha-reduced C19 steroids inhibit the aromatase reaction in vitro.大鼠卵巢排卵前卵泡发育过程中颗粒细胞芳香化酶活性的变化,并有证据表明5α-还原C19类固醇在体外抑制芳香化酶反应。
J Endocrinol. 1980 Mar;84(3):409-19. doi: 10.1677/joe.0.0840409.
10
The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione.酮康唑和4-羟基雄烯二酮等咪唑类药物对人前列腺芳香化酶活性的抑制作用。
Biochem Pharmacol. 1990 Oct 1;40(7):1569-75. doi: 10.1016/0006-2952(90)90456-u.

引用本文的文献

1
Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays.内分泌干扰物的识别与评估:体内和体外试验的局限性
Environ Health Perspect. 1998 Apr;106 Suppl 2(Suppl 2):577-82. doi: 10.1289/ehp.98106577.